Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CY 216

Known as: CY-216, CY216 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
Sixty-one consecutive patients were enrolled in a randomized, controlled trial of thromboprophylaxis with a low molecular weight… Expand
1993
1993
The inhibiting effect of standard heparin, CY216 and the ATIII-binding synthetic pentasaccharide on extrinsic and intrinsic… Expand
1993
1993
Summary. This study compares the ability of unfractionated heparin (UH) and of three low molecular weight heparins (LMWHs) to… Expand
1992
1992
In 14 patients undergoing chronic hemodialysis, we investigated the safety and efficacy of the low molecular fragment (CY-216) in… Expand
1992
1992
Three fractions of the low molecular weight heparin CY216 (fraxiparin, mean molecular weight [MMW] 5,090), with MMWs of… Expand
1991
1991
Low molecular weight (LMW) heparin preparations have unknown distributions of ATIII-binding material, so mean molecular weights… Expand
1990
1990
Ninety consecutive outpatients with acute proximal and/or distal deep-vein thrombosis (DVT), as shown by phlebography, were… Expand
Highly Cited
1986
Highly Cited
1986
On decrit la biodisponibilite et l'accumulation possible d'une heparine de faible poids moleculaire, CY216, et sa neutralisation… Expand
1986
1986
Unfractionated heparin, pentosan polysulphate (SP54) and the low molecular weight heparins CY216 and CY222 were injected… Expand
Highly Cited
1985
Highly Cited
1985
The efficacy and safety of a low‐molecular‐weight (LMW) heparin fraction in preventing postoperative venous thrombo‐embolism, was… Expand